← Back to Search

Non-Pharmacological Intervention

Brain Stimulation for Age-Related Memory Decline

N/A
Recruiting
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must have no history of neurological problems or head injury
Must not be taking any psychoactive medication
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during sham intervention
Awards & highlights

Study Summary

This trial will explore whether age-related memory decline is due to inefficient brain activity and whether this can be improved.

Who is the study for?
This trial is for older adults aged 68-80 with normal cognitive function (as shown by specific mental exams), no psychoactive medication use, and good vision. They must not have electronic implants, metal in the head, skin sensitivity issues, depression, neurological problems or a history of head injury.Check my eligibility
What is being tested?
The study tests if high definition transcranial electrical current stimulation can improve memory and cognition in older adults by enhancing brain activity patterns. It's non-drug based and could lead to new treatments for age-related cognitive decline.See study design
What are the potential side effects?
Potential side effects may include discomfort at the electrode sites on the scalp, mild headaches or dizziness post-treatment. However, this technique is generally considered safe with minimal adverse effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have never had a head injury or neurological problems.
Select...
I am not on any psychoactive medication.
Select...
My vision, with or without glasses, is normal, including seeing colors.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during sham intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and during sham intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Memory performance speed (active stimulation condition)
Memory performance speed (sham stimulation condition)
Memory performance success (active stimulation condition)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: active stimulationExperimental Treatment1 Intervention
Group II: sham stimulationPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Boston University Charles River CampusLead Sponsor
113 Previous Clinical Trials
11,591 Total Patients Enrolled

Media Library

High definition transcranial electrical current stimulation (Non-Pharmacological Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04362696 — N/A
Age-Related Memory Decline Research Study Groups: active stimulation, sham stimulation
Age-Related Memory Decline Clinical Trial 2023: High definition transcranial electrical current stimulation Highlights & Side Effects. Trial Name: NCT04362696 — N/A
High definition transcranial electrical current stimulation (Non-Pharmacological Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04362696 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are being incorporated into this research trial?

"Affirmative. Based on the information published at clinicaltrials.gov, this study is continuing to accept patients. First posted in September 2019 and last amended in March 2022, it aims to recruit 570 individuals from a single site."

Answered by AI

Is this research endeavor accepting participants over the age of 45?

"Participants of this research trial must be 18 years old or older, with an upper age limit of 80."

Answered by AI

Who is the target population for this clinical trial?

"This clinical trial seeks 570 seniors between the ages of 68 and 80 (with an exception for Experiment 1, allowing 18-30 year olds). Applicants must meet a range of criteria including normal or corrected vision, no pregnancy status, lack of metal implants in head/electronic devices implanted within their bodies, no history of neurological issues or physical trauma to the cranium. Additionally, those involved in this study cannot have any skin sensitivity or suffer from claustrophobia; they also require scores below 13 on Beck Depression Inventory II and Geriatric Depression Scale with scores above 24-30 on Mini Mental State Examination while not taking psychoactive drugs."

Answered by AI

Is the enrollment period for this trial still open?

"Affirmative. According to clinicaltrials.gov, this trial was initially posted on September 1st 2019 and subsequently updated on March 29th 2022. This medical research is looking for 570 participants from a single site."

Answered by AI
~10 spots leftby Apr 2024